J.P. Morgan analyst Daniel Kerven maintained a Buy rating on RELX plc (RLXXF – Research Report) today and set a price target of £42.50.
For all latest news, follow The Daily Star's Google News channel. The Stanford/Elsevier's Top 2% Scientist Rankings, now in its sixth iteration, lists the world's leading researchers. These ...
MitoRx Therapeutics (MitoRx), a platform biotechnology company developing novel mitochondrial-targeted sulfide-donor therapeutics (mtH2SD) in obesity-related disorders and myopathies announces a ...
Benzoyl peroxide degrades into the carcinogen benzene over time when stored at room temperature, at elevated temperatures and ...
Seniors age 75 will lose on average more than four years of life if they keep smoking, compared to people who never smoked, ...
After hours: October 14 at 5:04 PM EDT Loading Chart for ICLR ...
Up to 46 per cent of women in Europe and the United States chose not to go for subsequent mammogram screening after experiencing the pain of breast compression, according to one study in Elsevier, ...
aDepartment of Hematology/Oncology, Comprehensive Cancer Center (CCC Munich), LMU University Hospital Munich, 81377 Munich, Germany bDepartment of Hematology, Oncology, and Cancer Immunology (CCM), ...